Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes
Editorial Group: Cochrane Heart Group
Published Online: 12 MAY 2010
Assessed as up-to-date: 30 SEP 2009
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database of Systematic Reviews 2010, Issue 5. Art. No.: CD004587. DOI: 10.1002/14651858.CD004587.pub2.
- Publication Status: Edited (no change to conclusions)
- Published Online: 12 MAY 2010
This article has been cited by:
- 1Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial, EuroIntervention, 2014, 10, 1, 58, , , , , , , , , , ,
- 2ACCF 2012 Health Policy Statement on Patient-Centered Care in Cardiovascular Medicine, Journal of the American College of Cardiology, 2012, 59, 23, 2125, , , , , , , , , , , , , , , , , , , ,
- 3Another View of Personalized Medicine: Optimizing Stent Selection on the Basis of Predicted Benefit in Percutaneous Coronary Intervention, Trends in Cardiovascular Medicine, 2012, 22, 1, 23, ,